Researchers demonstrate the presence of beta-amyloid dimers in the brains of patients with Alzheimer’s
The most widely used biomarkers for the early detection of Alzheimer's disease (AD) are currently the concentrations of beta-amyloid and phosphorylated Tau in cerebrospinal fluid....








